Recent studies have shed light on the clinical relevance of urinary hepcidin mitigating acute kidney injury by promoting iron sequestration and thereby limiting oxidative stress, free radical damage, and renal injury in cardiac surgery patients [13,14]. The gene discussed is HAMP; the disease is acute kidney injury.